(BUSA) 2023 EFT Series Trust - Overview
Etf: U.S. Stocks, Active Management, Value Style, Equity Securities, Exchange-Traded
Dividends
| Dividend Yield | 1.63% |
| Yield on Cost 5y | 2.31% |
| Yield CAGR 5y | 29.86% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 11.5% |
| Relative Tail Risk | 0.10% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.89 |
| Alpha | 8.14 |
| Character TTM | |
|---|---|
| Beta | 0.705 |
| Beta Downside | 0.810 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.19% |
| CAGR/Max DD | 1.57 |
Description: BUSA 2023 EFT Series Trust December 31, 2025
The Brandes U.S. Value ETF (BUSA) is an actively managed fund that targets large-cap U.S. equities with a value tilt, allocating at least 80 % of its net assets (plus any investment-purpose borrowings) to U.S. company securities under normal market conditions.
Key quantitative facts (as of 2024 Q3): the fund carries an expense ratio of 0.68 %, holds roughly $1.2 billion in assets under management, and its top ten holdings are concentrated in sectors such as Financials, Energy, and Consumer Staples-areas historically sensitive to interest-rate cycles and commodity price movements. The ETF’s 12-month trailing return of 8.4 % modestly outperformed the Russell 1000 Value Index’s 7.9 % during the same period, reflecting the manager’s stock-selection skill but also exposing the portfolio to the same macro-risk drivers that affect the broader value premium.
Because value strategies tend to perform better when inflation expectations ease and real earnings growth accelerates, monitoring the Fed’s policy stance and corporate earnings revisions is essential for assessing BUSA’s upside potential.
For a deeper quantitative comparison, you might explore ValueRay’s analytical tools.
What is the price of BUSA shares?
Over the past week, the price has changed by +1.36%, over one month by +3.37%, over three months by +12.23% and over the past year by +18.78%.
Is BUSA a buy, sell or hold?
What are the forecasts/targets for the BUSA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 43.8 | 13.1% |
BUSA Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 301.3m USD (301.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 301.3m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 301.3m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.51% (E(301.3m)/V(301.3m) * Re(8.51%) + (debt-free company))
Discount Rate = 8.51% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)